Abstract
Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease, including diabetic nephropathy. Endothelial-derived nitric oxide synthase (eNOS) gene polymorphisms affect eNOS activity and are associated with endothelial dysfunction. We evaluated the association of the constitutive endothelial nitric oxide synthase gene (eNOS) polymorphisms with type 2 diabetic nephropathy. We genotyped three polymorphisms of eNOS (Two SNPs: −786T > C, 894G > T and one 27-bp repeat polymorphism in Intron 4 (27VNTR)) in type 2 diabetic nephropathy patients (cases: n = 195) and type 2 diabetic without nephropathy (controls: n = 255), using validated PCR-RFLP assays. We measured serum NO levels in these subjects and examined its correlation with diabetic nephropathy and eNOS genotypes. The frequency of CC (−786T > C), TT (894G > T) and aa genotypes (27VNTR) were significantly higher in diabetic nephropathy patients as compared to the diabetes without nephropathy group (CC: P = 0.003, TT: P = 0.03, aa: P < 0.0001). These mutant genotypes were found to be associated with higher risk of nephropathy (−786T > C: OR: 5.5, 95%CI: 1.53–19.79; 894G > T: OR: 1.8, 95%CI: 1.03–3.16; Intron 4: OR: 6.23, 95%CI: 2.23–16.31). Haplotype with all the wild alleles (T-b-G) was found to be associated with a decreased risk of nephropathy (OR: 0.68, P = 0.005) and haplotype with all mutant alleles (C-a-T) was associated with higher risk of diabetic nephropathy as compared to diabetes without nephropathy group (OR: 2.6, P = 0.14). No significant linkage disequilibria were observed among the variants in this case–control study. The serum NO levels were observed to be significantly (P < 0.05) lower in mutant allele carriers (‘C’ allele of T-786C SNP and/or ‘T’ allele of G894T SNP) as compared with the wild-type allele carriers (−786T and/or 894G) within each of the subject groups (with and without nephropathy). These results suggest that the eNOS gene locus is associated with diabetic nephropathy and the functional polymorphisms (−786T > C & 894G > T) might lead to a decreased expression of eNOS gene.
Similar content being viewed by others
References
Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. New Engl J Med 329:2002–2012
Star RA (1997) Intrarenal localizations of nitric oxide synthase isoforms and soluble guanylyl cyclase. Clin Exp Pharmacol Physiol 24:607–610
Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142
Schmidt HHHW, Walter U (1994) NO at work. Review. Cell 78:919–925
Loscalzo J, Welch G (1995) Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 38:87–104
Cooke JP, Tsao PS (1994) Is NO an endogenous anti-atherogenic molecule? Arterioscler Thromb 14:653–655
Lefer AM (1997) Nitric oxide: nature’s naturally occurring leukocyte inhibitor. Circulation 95:553–554
Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774–1777
Prabhakar SS (2004) Role of nitric oxide in diabetic nephropathy. Rev Semin Nephrol 24(4):333–344
Nakagawa T, Sato W, Glushakova O et al (2007) Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 18(2):539–550
Sharma K, McCue P, Dunn SR (2003) Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 284:F1138–F1144
Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS (2000) Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 57:405–413
Li C, Dong Y, Lu W (2001) The association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy. Zhonghua Nei Ke Za Zhi 40:729–732 (in Chinese)
Asakimori Y, Yorioka N, Yamamoto I, Okumoto S, Doi S, Hirai T et al (2001) Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease. Nephron 89:219–223
Zhao HJ, Wang S, Cheng H et al (2006) Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 17(10):2664–2669
Neugebauer S, Baba T, Watanabe T (2000) Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 49:500–503
Shimizu T, Onuma T, Kawamori R, Makita Y, Tomino Y (2002) Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Res Clin Pract 58:179–185
Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC (2003) Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 46:426–428
Weekers L, Hadjadj S, Belloum R, Gallois Y, Bouhanick B, Marre M (1999) Lack of contribution of two endothelial nitric oxide synthase (eNOS) gene polymorphisms to diabetic nephropathy in type 1 diabetes. Diabetologia 42:A266 (Abstr.)
Fujita H, Narita T, Meguro H, Ishii T, Hanyu O, Suzuki K et al (2000) Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy. Horm Metab Res 32:80–83
Pieper GM, Siebeneich W, Moore-Hilton G, Roza AM (1997) Reversal by l-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat. Diabetologia 40:910–915
Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S et al (1999) A common variant of the endothelial nitric oxide synthase (Glu298Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100:1515–1520
Lembo G, DeLuca N, Battagli C, Iovino G, Aretini A, Musicco M et al (2001) A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 32:735–740
Colombo MG, Andreassi MG, Paradossi U, Botto N, Manfredi S, Masetti S et al (2002) Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart 87:525–528
Noiri E, Satoh H, Taguchi J, Brodsky SV, Nakao A, Ogawa Y et al (2002) Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 40:535–540
Nagase S, Suzuki H, Wang Y, Kikuchi S, Hirayama A, Ueda A et al (2003) Association of ecNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem 244:113–118
Suzuki H, Nagase S, Kikuchi S, Wang Y, Koyama A (2000) Association of a missense Glu298Asp mutation of the endothelial nitric oxide synthase gene with end stage renal disease. Clin Chem 46:1858–1860
Asakimori Y, Yorioka N, Taniguchi Y, Ito T, Ogata S, Kyuden Y et al (2002) T(−786)C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease. Nephron 91:747–751
Shaw PKC, Baboe F, Es LA, Vijver JC, Ree MA, Jonge N, Rabelink TJ (2006) South Indian Type 2 diabetic patients have higher incidence and faster progression of Renal Disease compared with Dutch-European diabetic population. Diabetes Care 29:1383–1385
Kalinowski L, Dobrucki IT, Malinski T (2004) Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation 109:2511–2517
Karvonen J, Kauma H, Kervinen K, Rantala M, Ikaheimo M, Paivansalo M et al (2002) Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 251:102–110
Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H et al (1998) Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 31:1506–1510
Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilchen DEL (1996) A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2:41–45
Lepoivre M, Chenal B, Vapo A, Lamair G, Thalander L, Tenu JP (1990) Alteration of ribonucleotide reductase activity following induction of nitrite generating pathway in adenocarcinoma cells. J Biol Chem 265:14143–14149
Gordon D, Finch SJ, Nothnagel M, Ott J (2002) Power and sample size calculations for case–control genetic association tests when errors present: application to single nucleotide polymorphisms. Hum Hered 54:22–33
Gordon D, Levenstien MA, Finch SJ, Ott J (2003) Errors and linkage disequilibrium interact multiplicatively when computing sample sizes for genetic case–control association studies. Pac Sympos Biocomput 490–501
Cockram CS (2000) The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Med J 6(1):43–52
Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, Fujita T et al (1998) Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 32:521–526
Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M et al (1998) Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32:3–8
Yoshimura T, Yoshimura M, Tabata A et al (2000) Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia. J Soc Gynecol Invest 7:238–241
Fatini C, Sofi F, Sticchi E et al (2005) eNOS G894T polymorphism as a mild predisposing factor for abdominal aortic aneurysm. J Vasc Surg 42:415–419
Ozum U, Bolat N, Gul E et al (2008) Endothelial nitric oxide synthase gene [G894T] polymorphism as a possible risk factor in aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 150:57–61
Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H et al (1999) (−786)T > C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864–2870
Bank N, Aynedjian HS (1993) Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 43:1306–1312
Fairchild TA, Fulton D, Fontana JT, Gratton J-P, McCabe TJ, Sessa WC (2001) Acidic hydrolysis as a mechanism for the cleavage of the Glu298Asp variant of human endothelial nitric-oxide synthase. J Biol Chem 276:26674–26679
Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA 97:2832–2835
Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801–809
Osborn L, Hession C, Tizard R et al (1989) Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59:1203–1211
Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE (2007) Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 16(3):348–355
Herrington D (2005) Eliminating the improbable: Sherlock Holmes and standards of evidence in the genomic age. Circulation 112:2081–2084
Hattersley AT, McCarthy MI (2005) What makes a good genetic association study? Lancet 366:1315–1323
Neale BM, Sham PC (2004) The future of association studies: gene-based analysis and replication. Am J Hum Genet 75:353–362
Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434–442
Acknowledgements
This Genetic study carried out at Hypertension Genomics Laboratory, PGIMER, Chandigarh, India. Tarunveer S. Ahluwalia and Taranjit S. Rai were receiving research fellowships from Indian council of Medical research. We are grateful to the volunteers in this study, the laboratory staff, and all who gave their time to take part in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahluwalia, T.S., Ahuja, M., Rai, T.S. et al. Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians. Mol Cell Biochem 314, 9–17 (2008). https://doi.org/10.1007/s11010-008-9759-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-008-9759-8